![Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio](https://journals.asm.org/cms/10.1128/mBio.00567-18/asset/0664b8b1-a9da-4542-a100-4cbfdbb4f8cb/assets/graphic/mbo0031839550009.jpeg)
Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio
![CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy | Cancer Cell International | Full Text CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy | Cancer Cell International | Full Text](https://media.springernature.com/full/springer-static/image/art%3A10.1186%2Fs12935-020-01546-8/MediaObjects/12935_2020_1546_Fig2_HTML.png)
CRISPR-Cas, a robust gene-editing technology in the era of modern cancer immunotherapy | Cancer Cell International | Full Text
![Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio](https://journals.asm.org/cms/10.1128/mBio.00567-18/asset/9ac65221-f85a-43c2-b691-b285e7ae7d79/assets/graphic/mbo0031839550001.jpeg)
Introduction of Large Sequence Inserts by CRISPR-Cas9 To Create Pathogenicity Mutants in the Multinucleate Filamentous Pathogen Sclerotinia sclerotiorum | mBio
![Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair | Gene Therapy Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair | Gene Therapy](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41434-021-00251-z/MediaObjects/41434_2021_251_Fig1_HTML.png)
Correction of X-CGD patient HSPCs by targeted CYBB cDNA insertion using CRISPR/Cas9 with 53BP1 inhibition for enhanced homology-directed repair | Gene Therapy
![Horticulturae | Free Full-Text | CRISPR-Cas9 Gene Editing for Fruit and Vegetable Crops: Strategies and Prospects Horticulturae | Free Full-Text | CRISPR-Cas9 Gene Editing for Fruit and Vegetable Crops: Strategies and Prospects](https://www.mdpi.com/horticulturae/horticulturae-07-00193/article_deploy/html/images/horticulturae-07-00193-g001.png)
Horticulturae | Free Full-Text | CRISPR-Cas9 Gene Editing for Fruit and Vegetable Crops: Strategies and Prospects
![Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9 - ScienceDirect Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9 - ScienceDirect](https://ars.els-cdn.com/content/image/1-s2.0-S0167488916301781-gr1.jpg)
Insert, remove or replace: A highly advanced genome editing system using CRISPR/Cas9 - ScienceDirect
![Application of different types of CRISPR/Cas-based systems in bacteria | Microbial Cell Factories | Full Text Application of different types of CRISPR/Cas-based systems in bacteria | Microbial Cell Factories | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs12934-020-01431-z/MediaObjects/12934_2020_1431_Fig2_HTML.png)